Cargando…

MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition

Docetaxel is commonly used as an effective chemotherapeutic agent in breast cancer treatment, but the underlying mechanisms of drug resistance are not fully understood. The purpose of this study was to investigate the possible role of miR-129-3p in breast cancer cell resistance to docetaxel. MiR-129...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuan, Wang, Yu, Wei, Yifang, Li, Mengyang, Yu, Shentong, Ye, Mingxiang, Zhang, Hongmei, Chen, Suning, Liu, Wenchao, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614026/
https://www.ncbi.nlm.nih.gov/pubmed/26487539
http://dx.doi.org/10.1038/srep15424

Ejemplares similares